DekaBank Deutsche Girozentrale
ARIA

DekaBank Deutsche Girozentrale’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-104,100
Closed -$1.31M – 1044
2016
Q4 		$1.31M Buy
104,100
+7,900
+8% +$95.1K 0.01% 500
2016
Q3 		$1.32M Hold
96,200
– – 0.01% 501
2016
Q2 		$718K Buy
96,200
+14,700
+18% +$110K 0.01% 600
2016
Q1 		$505K Sell
81,500
-14,500
-15% -$81.3K 0.01% 654
2015
Q4 		$609K Buy
96,000
+1,000
+1% +$6.56K 0.01% 655
2015
Q3 		$555K Buy
95,000
+4,000
+4% +$30.8K 0.01% 674
2015
Q2 		$753K Buy
91,000
+3,000
+3% +$26.5K 0.01% 614
2015
Q1 		$725K Sell
88,000
-12,000
-12% -$88.7K 0.01% 626
2014
Q4 		$682K Sell
100,000
-9,500
-9% -$59.4K 0.01% 633
2014
Q3 		$591K Buy
109,500
+2,500
+2% +$14.6K 0.01% 618
2014
Q2 		$682K Sell
107,000
-3,500
-3% -$24.1K 0.01% 560
2014
Q1 		$891K Buy
110,500
+5,000
+5% +$38.9K 0.01% 488
2013
Q4 		$691K Buy
105,500
+2,300
+2% +$12.4K 0.01% 501
2013
Q3 		$1.9M Buy
+103,200
New +$2M 0.03% 326

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ARIA Position: Q1 2017 in Review

DekaBank Deutsche Girozentrale sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 104,100 shares — an estimated $1.31M sold.

DekaBank Deutsche Girozentrale first reported a position in ARIA in Q3 2013 and held it in 14 quarters. The position peaked at $1.9M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • DekaBank Deutsche Girozentrale reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 104,100 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.31M.
  • DekaBank Deutsche Girozentrale first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 14 quarters.
  • DekaBank Deutsche Girozentrale's Ariad Pharmaceuticals Inc position peaked at $1.9M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2017, filed 2 May 2017.